{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:11:28Z","timestamp":1795093888392,"version":"4.10.2"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is the most widespread tick-born zoonotic bunyavirus that causes severe hemorrhagic fever and death in humans. CCHFV enters the cell via clathrin-mediated endocytosis which is dependent on its surface glycoproteins. However, the cellular receptors that are required for CCHFV entry are unknown. Here we show that the low density lipoprotein receptor (LDLR) is an entry receptor for CCHFV. Genetic knockout of LDLR impairs viral infection in various CCHFV-susceptible human, monkey and mouse cells, which is restored upon reconstitution with ectopically-expressed LDLR. Mutagenesis studies indicate that the ligand binding domain (LBD) of LDLR is necessary for CCHFV infection. LDLR binds directly to CCHFV glycoprotein Gc with high affinity, which supports virus attachment and internalization into host cells. Consistently, a soluble sLDLR\u2013Fc fusion protein or anti-LDLR blocking antibodies impair CCHFV infection into various susceptible cells. Furthermore, genetic knockout of LDLR or administration of an LDLR blocking antibody significantly reduces viral loads, pathological effects and death following CCHFV infection in mice. Our findings suggest that LDLR is an entry receptor for CCHFV and pharmacological targeting of LDLR may provide a strategy to prevent and treat Crimean-Congo hemorrhagic fever.<\/jats:p>","DOI":"10.1038\/s41422-023-00917-w","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T10:02:56Z","timestamp":1704448976000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["LDLR is an entry receptor for Crimean-Congo hemorrhagic fever virus"],"prefix":"10.1038","volume":"34","author":[{"given":"Zhi-Sheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-2417","authenticated-orcid":false,"given":"Yan-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"917_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6, 203\u2013214 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"917_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","volume":"100","author":"DA Bente","year":"2013","unstructured":"Bente, D. A. et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 100, 159\u2013189 (2013).","journal-title":"Antiviral Res."},{"key":"917_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/vbz.2012.1061","volume":"13","author":"E Akinci","year":"2013","unstructured":"Akinci, E., Bodur, H. & Leblebicioglu, H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 13, 429\u2013437 (2013).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"917_CR4","doi-asserted-by":"crossref","unstructured":"Zivcec, M., Scholte, F. E. M., Spiropoulou, C. F., Spengler, J. R. & Bergeron, E. Molecular insights into Crimean-Congo hemorrhagic fever virus. Viruses 8, 106 (2016).","DOI":"10.3390\/v8040106"},{"key":"917_CR5","doi-asserted-by":"crossref","unstructured":"Hawman, D. W. & Feldmann, H. Recent advances in understanding Crimean-Congo hemorrhagic fever virus. F1000Res 7(F1000 Faculty Rev), 1715 (2018).","DOI":"10.12688\/f1000research.16189.1"},{"key":"917_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand, M. S., Al-Shorbaji, F., Millett, P. & Murgue, B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 159, 63\u201367 (2018).","journal-title":"Antiviral Res."},{"key":"917_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41579-023-00871-9","volume":"21","author":"DW Hawman","year":"2023","unstructured":"Hawman, D. W. & Feldmann, H. Crimean-Congo haemorrhagic fever virus. Nat. Rev. Microbiol. 21, 463\u2013477 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"917_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/JVI.80.1.514-525.2006","volume":"80","author":"AJ Sanchez","year":"2006","unstructured":"Sanchez, A. J., Vincent, M. J., Erickson, B. R. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J. Virol. 80, 514\u2013525 (2006).","journal-title":"J. Virol."},{"key":"917_CR9","doi-asserted-by":"publisher","first-page":"13271","DOI":"10.1128\/JVI.01647-07","volume":"81","author":"E Bergeron","year":"2007","unstructured":"Bergeron, E., Vincent, M. J. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1\/S1P is critical for virus infectivity. J. Virol. 81, 13271\u201313276 (2007).","journal-title":"J. Virol."},{"key":"917_CR10","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1128\/JVI.77.16.8640-8649.2003","volume":"77","author":"MJ Vincent","year":"2003","unstructured":"Vincent, M. J. et al. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. 77, 8640\u20138649 (2003).","journal-title":"J. Virol."},{"key":"917_CR11","doi-asserted-by":"crossref","unstructured":"Hulswit, R. J. G., Paesen, G. C., Bowden, T. A & Shi, X. Recent advances in bunyavirus glycoprotein research: precursor processing, receptor binding and structure. Viruses 13, 353 (2021).","DOI":"10.3390\/v13020353"},{"key":"917_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virs.2022.01.015","volume":"37","author":"N Li","year":"2022","unstructured":"Li, N. et al. Cryo-EM structure of glycoprotein C from Crimean-Congo hemorrhagic fever virus. Virol. Sin. 37, 127\u2013137 (2022).","journal-title":"Virol. Sin."},{"key":"917_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.abl6502","volume":"375","author":"AK Mishra","year":"2022","unstructured":"Mishra, A. K. et al. Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies. Science 375, 104\u2013109 (2022).","journal-title":"Science"},{"key":"917_CR14","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","unstructured":"Bertolotti-Ciarlet, A. et al. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins. J. Virol. 79, 6152\u20136161 (2005).","journal-title":"J. Virol."},{"key":"917_CR15","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","volume":"184","author":"JM Fels","year":"2021","unstructured":"Fels, J. M. et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell 184, 3486\u20133501.e21 (2021).","journal-title":"Cell"},{"key":"917_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1099\/vir.0.006387-0","volume":"90","author":"M Simon","year":"2009","unstructured":"Simon, M., Johansson, C. & Mirazimi, A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 90, 210\u2013215 (2009).","journal-title":"J. Gen. Virol."},{"key":"917_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.virol.2013.05.030","volume":"444","author":"AR Garrison","year":"2013","unstructured":"Garrison, A. R. et al. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 444, 45\u201354 (2013).","journal-title":"Virology"},{"key":"917_CR18","doi-asserted-by":"crossref","unstructured":"Shtanko, O., Nikitina, R. A., Altuntas, C. Z., Chepurnov, A. A., Davey, R. A. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog. 10 (2014).","DOI":"10.1371\/journal.ppat.1004390"},{"key":"917_CR19","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/JVI.02070-06","volume":"81","author":"AM Connolly-Andersen","year":"2007","unstructured":"Connolly-Andersen, A. M., Magnusson, K. E. & Mirazimi, A. Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 81, 2158\u20132164 (2007).","journal-title":"J. Virol."},{"key":"917_CR20","doi-asserted-by":"publisher","first-page":"e0008863","DOI":"10.1371\/journal.pntd.0008863","volume":"14","author":"V Monteil","year":"2020","unstructured":"Monteil, V., Salata, C., Appelberg, S. & Mirazimi, A. Hazara virus and Crimean-Congo Hemorrhagic Fever Virus show a different pattern of entry in fully-polarized Caco-2 cell line. PLoS Negl. Trop. Dis. 14, e0008863 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"917_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0092-8674(84)90527-0","volume":"38","author":"S Fuller","year":"1984","unstructured":"Fuller, S., von Bonsdorff, C. H. & Simons, K. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell 38, 65\u201377 (1984).","journal-title":"Cell"},{"key":"917_CR22","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.1073\/pnas.1608821113","volume":"113","author":"EA Moreira","year":"2016","unstructured":"Moreira, E. A. et al. Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism. Proc. Natl. Acad. Sci. USA 113, 12797\u201312802 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR23","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein, D., Werman, A., Novick, D., Barak, S. & Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 110, 7306\u20137311 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ncb827","volume":"4","author":"Y Gan","year":"2002","unstructured":"Gan, Y., McGraw, T. E. & Rodriguez-Boulan, E. The epithelial-specific adaptor AP1B mediates post-endocytic recycling to the basolateral membrane. Nat. Cell Biol. 4, 605\u2013609 (2002).","journal-title":"Nat. Cell Biol."},{"key":"917_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"917_CR26","first-page":"19","volume":"85","author":"GW Go","year":"2012","unstructured":"Go, G. W. & Mani, A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J. Biol. Med. 85, 19\u201328 (2012).","journal-title":"Yale J. Biol. Med."},{"key":"917_CR27","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/j.1460-2075.1996.tb00623.x","volume":"15","author":"TE Willnow","year":"1996","unstructured":"Willnow, T. E. et al. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15, 2632\u20132639 (1996).","journal-title":"EMBO J."},{"key":"917_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-021-04326-0","volume":"602","author":"LE Clark","year":"2022","unstructured":"Clark, L. E. et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature 602, 475\u2013480 (2022).","journal-title":"Nature"},{"key":"917_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbrc.2011.06.109","volume":"411","author":"XD Xiao","year":"2011","unstructured":"Xiao, X. D., Feng, Y., Zhu, Z. Y. & Dimitrov, D. S. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 411, 253\u2013258 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"917_CR30","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1073\/pnas.78.4.2268","volume":"78","author":"T Kita","year":"1981","unstructured":"Kita, T., Brown, M. S., Watanabe, Y. & Goldstein, J. L. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 78, 2268\u20132272 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR31","doi-asserted-by":"crossref","unstructured":"Lindquist, M. E. et al. Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice. J. Virol. 92, e01083-18 (2018).","DOI":"10.1128\/JVI.01083-18"},{"key":"917_CR32","doi-asserted-by":"publisher","first-page":"11089","DOI":"10.1128\/JVI.01383-10","volume":"84","author":"DA Bente","year":"2010","unstructured":"Bente, D. A. et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089\u201311100 (2010).","journal-title":"J. Virol."},{"key":"917_CR33","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","volume":"91","author":"S Bereczky","year":"2010","unstructured":"Bereczky, S. et al. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 91, 1473\u20131477 (2010).","journal-title":"J. Gen. Virol."},{"key":"917_CR34","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/infdis\/jit061","volume":"207","author":"M Zivcec","year":"2013","unstructured":"Zivcec, M. et al. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha\/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J. Infect. Dis. 207, 1909\u20131921 (2013).","journal-title":"J. Infect. Dis."},{"key":"917_CR35","doi-asserted-by":"crossref","unstructured":"Hawman, D. W. et al. Crimean-Congo hemorrhagic fever mouse model recapitulating human convalescence. J. Virol. 93, e00554-19 (2019).","DOI":"10.1128\/JVI.00554-19"},{"key":"917_CR36","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00705-016-2803-1","volume":"161","author":"Y Suda","year":"2016","unstructured":"Suda, Y. et al. Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system. Arch. Virol. 161, 1447\u20131454 (2016).","journal-title":"Arch. Virol."},{"key":"917_CR37","doi-asserted-by":"crossref","unstructured":"Dai, S. Y. et al. Differential cell line susceptibility to Crimean-Congo hemorrhagic fever virus. Front. Cell. Infect. Microbiol. 11, 648077 (2021).","DOI":"10.3389\/fcimb.2021.648077"},{"key":"917_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1060458","volume":"292","author":"CK Garcia","year":"2001","unstructured":"Garcia, C. K. et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394\u20131398 (2001).","journal-title":"Science"},{"key":"917_CR39","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1469-0691.2004.01022.x","volume":"10","author":"RN Charrel","year":"2004","unstructured":"Charrel, R. N. et al. Tick-borne virus diseases of human interest in Europe. Clin. Microbiol. Infect. 10, 1040\u20131055 (2004).","journal-title":"Clin. Microbiol. Infect."},{"key":"917_CR40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOL.0b013e32833ded6a","volume":"21","author":"JF Bentzon","year":"2010","unstructured":"Bentzon, J. F. & Falk, E. Atherosclerotic lesions in mouse and man: is it the same disease? Curr. Opin. Lipidol. 21, 434\u2013440 (2010).","journal-title":"Curr. Opin. Lipidol."},{"key":"917_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/09680519030090060701","volume":"9","author":"S Lanza-Jacoby","year":"2003","unstructured":"Lanza-Jacoby, S. et al. Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. J. Endotoxin Res. 9, 341\u2013347 (2003).","journal-title":"J. Endotoxin Res."},{"key":"917_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall, A. R. & Yvan-Charvet, L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15, 104\u2013116 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"917_CR43","doi-asserted-by":"publisher","first-page":"117955142199067","DOI":"10.1177\/1179551421990675","volume":"14","author":"IS Atmosudigdo","year":"2021","unstructured":"Atmosudigdo, I. S. et al. Dyslipidemia increases the risk of severe COVID-19: a systematic review, meta-analysis, and meta-regression. Clin. Med. Insights Endocrinol. Diabetes 14, 1179551421990675 (2021).","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"917_CR44","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.4049\/jimmunol.2100927","volume":"208","author":"AY Louie","year":"2022","unstructured":"Louie, A. Y. et al. Dietary cholesterol causes inflammatory imbalance and exacerbates morbidity in mice infected with influenza A virus. J. Immunol. 208, 2523\u20132539 (2022).","journal-title":"J. Immunol."},{"key":"917_CR45","doi-asserted-by":"publisher","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","volume":"96","author":"V Agnello","year":"1999","unstructured":"Agnello, V., Abel, G., Elfahal, M., Knight, G. B. & Zhang, Q. X. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 96, 12766\u201312771 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR46","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1073\/pnas.91.5.1839","volume":"91","author":"F Hofer","year":"1994","unstructured":"Hofer, F. et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. USA 91, 1839\u20131842 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR47","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.25501","volume":"55","author":"A Albecka","year":"2012","unstructured":"Albecka, A. et al. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 55, 998\u20131007 (2012).","journal-title":"Hepatology"},{"key":"917_CR48","doi-asserted-by":"publisher","first-page":"e1005610","DOI":"10.1371\/journal.ppat.1005610","volume":"12","author":"S Yamamoto","year":"2016","unstructured":"Yamamoto, S. et al. Lipoprotein receptors redundantly participate in entry of hepatitis C virus. PLoS Pathog. 12, e1005610 (2016).","journal-title":"PLoS Pathog."},{"key":"917_CR49","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938\u2013941 (1998).","journal-title":"Science"},{"key":"917_CR50","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli, E. et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017\u20135025 (2002).","journal-title":"EMBO J."},{"key":"917_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801\u2013805 (2007).","journal-title":"Nature"},{"key":"917_CR52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","volume":"457","author":"A Ploss","year":"2009","unstructured":"Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882\u2013886 (2009).","journal-title":"Nature"},{"key":"917_CR53","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41586-020-2915-3","volume":"588","author":"H Ma","year":"2020","unstructured":"Ma, H. et al. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Nature 588, 308\u2013314 (2020).","journal-title":"Nature"},{"key":"917_CR54","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1016\/j.cell.2021.09.001","volume":"184","author":"SS Ganaie","year":"2021","unstructured":"Ganaie, S. S. et al. Lrp1 is a host entry factor for Rift Valley fever virus. Cell 184, 5163\u20135178.e24 (2021).","journal-title":"Cell"},{"key":"917_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05796-z","volume":"9","author":"HX Zhang","year":"2018","unstructured":"Zhang, H. X. et al. TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis. Nat. Commun. 9, 3441 (2018).","journal-title":"Nat. Commun."},{"key":"917_CR56","doi-asserted-by":"publisher","first-page":"23707","DOI":"10.1073\/pnas.2002472117","volume":"117","author":"WW Li","year":"2020","unstructured":"Li, W. W. et al. Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response. Proc. Natl. Acad. Sci. USA 117, 23707\u201323716 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12250-016-3936-9","volume":"32","author":"R Guo","year":"2017","unstructured":"Guo, R. et al. A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China. Virol. Sin. 32, 80\u201388 (2017).","journal-title":"Virol. Sin."},{"key":"917_CR58","doi-asserted-by":"crossref","unstructured":"Li, S. et al. NSs filament formation is important but not sufficient for RVFV virulence in vivo. Viruses 11, 834 (2019).","DOI":"10.3390\/v11090834"},{"key":"917_CR59","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.3389\/fmicb.2019.03111","volume":"10","author":"H Xia","year":"2019","unstructured":"Xia, H. et al. Characterization of Ebinur lake virus and its human seroprevalence at the China-Kazakhstan border. Front. Microbiol. 10, 3111 (2019).","journal-title":"Front. Microbiol."},{"key":"917_CR60","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1073\/pnas.1814336116","volume":"116","author":"ZS Xu","year":"2019","unstructured":"Xu, Z. S. et al. FAM64A positively regulates STAT3 activity to promote Th17 differentiation and colitis-associated carcinogenesis. Proc. Natl. Acad. Sci. USA 116, 10447\u201310452 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"917_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ REED","year":"1938","unstructured":"REED, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"917_CR62","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570\u2013574 (2018).","journal-title":"Nature"},{"key":"917_CR63","doi-asserted-by":"publisher","first-page":"105273","DOI":"10.1016\/j.antiviral.2022.105273","volume":"199","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 199, 105273 (2022).","journal-title":"Antiviral Res."}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41422-023-00917-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-023-00917-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-023-00917-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T12:08:37Z","timestamp":1706875717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41422-023-00917-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1038\/s41422-023-00917-w","relation":{},"ISSN":["1748-7838"],"issn-type":[{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}